This job has expired and is no longer accepting applications. Browse active roles in the same category or location below.
S
Other
Job details
Company
Scholarrock
Location
Remote, Germany
Employment type
Full-time
Primary category
Other
Posted date
3 Feb 2026
Valid through
4 Apr 2026
Job description
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn.
Summary of Position: Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn.
Summary of Position:
The Regional Business Leader is responsible for driving commercial success, shaping regional launch success, and developing strong relationships with key stakeholders within the rare disease ecosystem—with a specific and initial focus on Spinal Muscular Atrophy (SMA). The role combines high engagement field presence and strategic account management, ensuring timely and appropriate access to innovative therapies for patients living with SMA.
Execute territory and account-based sales plans to achieve commercial goals in the SMA therapeutic area, including identifying key accounts, prioritizing centers of excellence, and managing physician relationships. Proactively prospect, develop and expand relationships with clinicians involved in SMA diagnosis and treatment (neurologists, pediatric neurologists, clinical geneticists, hospitals). Deliver product presentations, educational conversations, and scientific discussions in a compliant manner, tailored to varying HCP needs. Manage complex sales cycles, ensuring strong presence and consistent follow-up in academic and hospital environments. Provide expertise in national and/or regional market access related matters Raise awareness about SMA, diagnostic pathways, genetic testing, early intervention, and treatment value—aligned with the company’s overall value proposition and story Develop deep, trusted relationships with neuromuscular KOLs, SMA centers, and hospital pharmacists Represent the organization at congresses, regional neurology events, peer to peer and scientific meetings. Work closely with Medical Affairs, Market Access, Marketing, and Patient Support Programs to ensure cohesive support for HCPs and patients Communicate market insights, treatment barriers, and customer feedback to inform strategy and operational planning. Comply with German regulatory standards (AMG, HWG), promotional codes, and company policies Ensure transparent and ethical interactions with HCPs.
Bachelor’s or Master’s degree in Life Sciences, Health Sciences, Business, or related field. 7+ years of commercial experience in biotech/pharmaceutical field sales, Proven track record in rare disease, neurology, or SMA/specialty care markets. Strong experience working with KOLs, hospital structures, and complex patient pathways in Germany Experience in the development of the German rare disease/SMA ecosystem Demonstrated success in product launches, national and regional Market Access activities, market development, and regional P&L leadership is a plus.
Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
Summary of Position: Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn.
Summary of Position:
The Regional Business Leader is responsible for driving commercial success, shaping regional launch success, and developing strong relationships with key stakeholders within the rare disease ecosystem—with a specific and initial focus on Spinal Muscular Atrophy (SMA). The role combines high engagement field presence and strategic account management, ensuring timely and appropriate access to innovative therapies for patients living with SMA.